-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory breast cancer (IBC) is an aggressive cancer that accounts for 1% to 6% of all breast cancers diagnosed
Inflammatory breast cancer (IBC) is an aggressive cancer that accounts for 1% to 6% of all breast cancers diagnosed
The standard of care for IBC is neoadjuvant chemotherapy, total mastectomy with axillary lymph node dissection (ALND), and post-mastectomy radiation therapy
This retrospective cohort study used the National Cancer Database, a nationwide hospital-based cancer registry, to enroll women diagnosed with non-metastatic IBC who underwent axillary surgery between 2012 and 2017
This retrospective cohort study used the National Cancer Database, a nationwide hospital-based cancer registry, to enroll women diagnosed with non-metastatic IBC who underwent axillary surgery between 2012 and 2017
A total of 1096 women were included in the study who were diagnosed with non-metastatic IBC between 2012 and 2017 and were 18 years of age or older
Utilization rate of sentinel lymph node biopsy (SLNB) in patients with non-metastatic inflammatory breast cancer
Rates of Sentinel Lymph Node Biopsy (SLNB) in Patients with Nonmetastatic Inflammatory Breast CancerFrom 2012 to 2017, the use of SLNB showed a statistically significant upward trend
From 2012 to 2017, the use of SLNB showed a statistically significant upward trend
In this study, the investigators used hospital cancer registry data representing the majority of newly diagnosed cancers in the United States to demonstrate the frequent and increasing use of SLNB among IBC patients
Reference: Sosa A, Lei X, Woodward WA, et al.
Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US.
JAMA Netw Open.
2022;5(2):e2148021.
doi:10.
1001/jamanetworkopen.
2021.
48021 Reference: Sosa A, Lei X, Woodward WA, et al.
Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US.
JAMA Netw Open.
2022;5(2):e2148021.
doi:10.
1001/jamanetworkopen .
2021.
48021 JAMA Netw Open.
JAMA doi:10.
1001/jamanetworkopen.
2021.
48021
Leave a comment here
